Finance

Lists
FORTIS:NSE
Fortis Healthcare Ltd
756,40 INR
-0,11%
(-0,85) 1D
13-окт., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for FORTIS...
Open
757,00 INR
High
767,70 INR
Low
745,20 INR
Mkt. cap
570,41 млд
Avg. vol.
1,73 млн
Volume
2,09 млн
Dividend
0,13%
Quarterly dividend
0,25 INR
Ex-dividend date
2026-ж., 24-июл.
P/E ratio
54,50
52-wk high
1 104,30 INR
52-wk low
745,20 INR
EPS
13,88 INR
Shares outstanding
519,08 млн
No. of employees
15 миң
Open
757,00 INR
High
767,70 INR
Low
745,20 INR
Mkt. cap
570,41 млд
Avg. vol.
1,73 млн
Volume
2,09 млн
Dividend
0,13%
Quarterly dividend
0,25 INR
Ex-dividend date
2026-ж., 24-июл.
P/E ratio
54,50
52-wk high
1 104,30 INR
52-wk low
745,20 INR
EPS
13,88 INR
Shares outstanding
519,08 млн
No. of employees
15 миң
News stories
From web sources and news partners
Profile
Fortis Healthcare Limited is an Indian for-profit private hospital network headquartered in Gurgaon. The Fortis Memorial Research Institute in Gurgaon serves as the headquarters for Fortis Healthcare. In addition to its Gurgaon facility, Fortis Healthcare operates hospitals in the Delhi NCR, including locations in Faridabad, Noida, Vasant Kunj, and Shalimar Bagh, along with other facilities across India, Dubai, and Sri Lanka. The company currently manages 36 healthcare facilities. Wikipedia
About Fortis Healthcare Ltd
CEOAshutosh Raghuvanshi
Employees14,6 миң
Founded1996
HeadquartersGurugram, Харайана, Индия
SectorHealth care provider
Last report
2026-ж., 7-авг.
Fiscal period
Q1 2027
3,62 INR / 3,75 INR
-3,42%miss
Revenue / Est. (INR)
25,45 млд / 25,08 млд
+1,47%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
23,31 млд
22,65 млд
23,65 млд
25,45 млд
Cost of goods sold
13,50 млд
13,37 млд
-3,56 млд
15,29 млд
Cost of revenue
13,50 млд
13,37 млд
-3,56 млд
15,29 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
4,29 млд
-
Operating expense
5,31 млд
5,42 млд
23,22 млд
6,01 млд
Total operating expenses
18,81 млд
18,80 млд
19,66 млд
21,30 млд
Operating income
4,50 млд
3,86 млд
3,98 млд
4,15 млд
Other non operating income
225,80 млн
82,90 млн
-709,53 млн
144,70 млн
EBT including unusual items
4,25 млд
2,66 млд
3,24 млд
3,63 млд
EBT excluding unusual items
4,02 млд
3,12 млд
3,33 млд
3,54 млд
Income tax expense
965,80 млн
682,80 млн
530,11 млн
903,80 млн
Effective tax rate
22,70%
25,70%
16,35%
24,89%
Other operating expenses
4,25 млд
4,22 млд
17,71 млд
4,79 млд
Net income
3,22 млд
1,94 млд
2,66 млд
2,66 млд
Net profit margin
13,81%
8,55%
11,24%
10,47%
Earnings per share
4,02
3,02
3,66
3,62
Interest and investment income
-
-
394,31 млн
-
Interest expense
-748,80 млн
-857,40 млн
-402,06 млн
-804,40 млн
Net interest expenses
-748,80 млн
-857,40 млн
-7,74 млн
-804,40 млн
Depreciation and amortization charges
1,06 млд
1,20 млд
1,22 млд
1,22 млд
EBITDA
5,54 млд
4,62 млд
4,87 млд
5,04 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору